Skip to main content
AmigoFish

Idiopathic Pulmonary Fibrosis - Treatment and New Hope

From MedCram - Medical Lectures Explained CLEARLY · · 16 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.

If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.

Watch on YouTube

Not rated yet

Description

Roger Seheult, MD of MedCram explains the history of idiopathic pulmonary fibrosis treatments, current medications, and a potential new treatment. See all Dr. Seheult's videos at: https://www.medcram.com/

(This video was recorded on April 9th, 2026)

Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/

He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

LINKS / REFERENCES:

2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (Lancet) | https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00223-5/abstract?utm_source

What Is Idiopathic Pulmonary Fibrosis? (American Thoracic Society) | https://www.thoracic.org/patients/patient-resources/resources/idiopathic-pulmonary-fibrosis-pt1.pdf?utm_source

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis (NEJM) | https://www.nejm.org/doi/full/10.1056/NEJMoa1113354?utm_source

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (NEJM) | https://www.nejm.org/doi/full/10.1056/NEJMoa1402582?utm_source

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (NEJM) | https://www.nejm.org/doi/full/10.1056/NEJMoa1402584?utm_source

FDA approves drug to treat idiopathic pulmonary fibrosis (FDA) | https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-idiopathic-pulmonary-fibrosis?utm_source

HIGHLIGHTS OF PRESCRIBING INFORMATION (FDA) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218764s000lbl.pdf

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial (Nature) | https://www.nature.com/articles/s41591-025-03743-2?utm_source

NEWSTART (NEWSTART) | https://newstart.com

SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:

https://www.youtube.com/user/MEDCRAMvideos?Exposure to a more unhealthy diet impacts sleep microstructure during normal sleep and recovery sleep: A randomized trial=1 Get notified of new videos by hitting the bell icon

MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.

MEDIA CONTACT:

Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact?utm_source=Youtube&utm_medium=Video&utm_campaign=Video+Link+Clicks&utm_term=Insights+Into+Cirrhotic+Bleeding+of+the+Liver%2C+and+How+to+Stop+It&utm_content=CaBnPmyY5kE

Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC

FOLLOW US ON SOCIAL MEDIA:

https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram

DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#IPF #fibrosis #pulmonary

Back to MedCram - Medical Lectures Explained CLEARLY · Report a problem